Six years ago Abiraterone was hailed as a medical breakthrough that could offer men extra time with loved ones and a chance to delay chemotherapy and its debilitating side effects.
Today the body that recommends what can and cannot be paid for said it 'wasn't cost effective'.
Prostate cancer patients have now been told that the life-extending drug will not be routinely prescribed unless they have chemotherapy.
One man from North Yorkshire who is fighting prostate cancer is calling for a rethink:
More top news
A teenager from Grimsby's now allergic to her school. Tiffiney Blakey's had four severe reactions and tests are being done to work out why.
Cyclist Lizzie Armitstead might not know when her upcoming wedding will be, but has no doubt it will be held somewhere in her home county.
A vulnerable man who accused Leon Brittan of sexual abuse has claimed he was encouraged to make the allegations by campaigners.